Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy

References

• Chittasupho C, Athikomkulchai S. Nanoparticles of Combretum quadrangulare leaf extract induce cytotoxicity, apoptosis, cell cycle arrest and anti-migration in lung cancer cells. J Drug Deliv Sci Tec. 2018;45:378–387.
   Web of Science ®Google Scholar
• Munaweera I, Shi Y, Koneru B, et al. Nitric oxide- and cisplatin-releasing silica nanoparticles for use against non-small cell lung cancer. J Inorg Biochem. 2015;153:23–31.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. J Control Release. 2015;209:88–100.
   PubMed Web of Science ®Google Scholar
• Kumar N, Salar RK, Prasad M, et al. Synthesis, characterization and anticancer activity of vincristine loaded folic acid-chitosan conjugated nanoparticles on NCI-H460 non-small cell lung cancer cell line. Egypt J Basic Appl Sci. 2018;5:87–99.
   Google Scholar
• Zhao Q-s, Hu L-l, Wang Z-d, et al. Resveratrol-loaded folic acid-grafted dextran stearate submicron particles exhibits enhanced antitumor efficacy in non-small cell lung cancers. Mat Sci Eng C-Mater. 2017;72:185–191.
   Web of Science ®Google Scholar
• Wen ZM, Jie J, Zhang Y, et al. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer. Biochem Bioph Res Co. 2017;493:1430–1437.
   PubMed Web of Science ®Google Scholar
• Ibrahim HG, Attia N, Hashem F, et al. Cerium oxide nanoparticles: In pursuit of liver protection against doxorubicin-induced injury in rats. Biomed Pharm. 2018;103:773–781.
   PubMed Web of Science ®Google Scholar
• Sun H, Liu Y, Bai X, et al. Induction of oxidative stress and sensitization of cancer cells to paclitaxel by gold nanoparticles with different charge densities and hydrophobicities. J Mater Chem B. 2018;6:1633–1639.
   PubMed Web of Science ®Google Scholar
• Li M, Tang Z, Zhang Y, et al. LHRH-peptide conjugated dextran nanoparticles for targeted delivery of cisplatin to breast cancer. J Mater Chem B. 2014;2:3490–3499.
   PubMed Web of Science ®Google Scholar
• Wang W, Chen T, Xu H, et al. Curcumin-loaded solid lipid nanoparticles enhanced anticancer efficiency in breast cancer. Molecules 2018;23:1578.
   PubMed Web of Science ®Google Scholar
• Xia Y, Lin Z, Li Y, et al. Targeted delivery of siRNA using RGDfC-conjugated functionalized selenium nanoparticles for anticancer therapy. J Mater Chem B. 2017;5:6941–6952.
   PubMed Web of Science ®Google Scholar
• Brown AL, Winter H, Goforth AM, et al. Facile synthesis of ligand-free iridium nanoparticles and their in vitro biocompatibility. Nanoscale Res Lett. 2018;13:208.
   PubMed Web of Science ®Google Scholar
• Li Y, Guo M, Lin Z, et al. Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce A549 cell apoptosis. Ijn. 2016;11:6693–6702.
   Web of Science ®Google Scholar
• Yu B, Tai HC, Xue W, et al. Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol. 2010;27:286–298.
   PubMed Web of Science ®Google Scholar
• Pedrosa SS, Pereira P, Correia A, et al. Targetability of hyaluronic acid nanogel to cancer cells: in vitro and in vivo studies. Eur J Pharm Sci. 2017;104:102–113.
   PubMed Web of Science ®Google Scholar
• Lin T, Yuan A, Zhao X, et al. Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer. Acta Biomater. 2017;53:427–438.
   PubMed Web of Science ®Google Scholar
• Xia Y, You P, Xu F, et al. Novel functionalized selenium nanoparticles for enhanced anti-hepatocarcinoma activity in vitro. Nanoscale Res Lett. 2015;10:1051.
   PubMed Web of Science ®Google Scholar
• Zheng W, Yin T, Chen Q, et al. Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III beta-tubulin in drug-resistant breast cancers. Acta Biomater. 2016;31:197–210.
   PubMed Web of Science ®Google Scholar
• Sun D, Liu Y, Yu Q, et al. Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles. Biomaterials. 2014;35:1572–1583.
   PubMed Web of Science ®Google Scholar
• Li Y, Lin Z, Guo M, et al. Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways. IJN. 2018;13:2005–2016.
   Web of Science ®Google Scholar
• Zhou Y, Yu Q, Qin X, et al. Improving the anticancer efficacy of laminin receptor-specific therapeutic ruthenium nanoparticles (RuBB-loaded EGCG-RuNPs) via ROS-dependent apoptosis in SMMC-7721 cells. ACS Appl Mater Interfaces. 2016;8:15000–15012.
   PubMed Web of Science ®Google Scholar
• Xia Y, Wang C, Xu T, et al. Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy. RSC Adv. 2018;8:1917–1926.
   PubMed Web of Science ®Google Scholar
• Yang C, Wang X, Yao X, et al. Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery. J Control Release. 2015;205:206–217.
   PubMed Web of Science ®Google Scholar
• Xia Y, Guo M, Xu T, et al. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy. IJN. 2018;13:1539–1552.
   Web of Science ®Google Scholar
• Sun D, Liu Y, Yu Q, et al. The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling. Biomaterials. 2013;34:171–180.
   PubMed Web of Science ®Google Scholar
• Xia Y, Chen Q, Qin X, et al. Studies of ruthenium(ii)-2,2′-bisimidazole complexes on binding to G-quadruplex DNA and inducing apoptosis in HeLa cells. New J Chem. 2013;37:3706–3715.
   Web of Science ®Google Scholar
• Yin T, Xie W, Sun J, et al. Penetratin peptide-functionalized gold nanostars: enhanced BBB permeability and NIR photothermal treatment of Alzheimer's disease using ultralow irradiance. ACS Appl Mater Interfaces. 2016;8:19291–19302.
   PubMed Web of Science ®Google Scholar
• Jeong JY, Hong EH, Lee SY, et al. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Acta Biomater. 2017;53:414–426.
   PubMed Web of Science ®Google Scholar
• Lin JT, Du JK, Yang YQ, et al. pH and redox dual stimulate-responsive nanocarriers based on hyaluronic acid coated mesoporous silica for targeted drug delivery. Mat Sci Eng C-Mater. 2017;81:478–484.
   Web of Science ®Google Scholar
• Xia Y, Xu T, Wang C, et al. Novel functionalized nanoparticles for tumortargeting co-delivery of doxorubicin and siRNA to enhance cancer therapy. IJN. 2018;13:143–159.
   Web of Science ®Google Scholar
• Kozlu S, Sahin A, Ultav G, et al. Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles. J Drug Deliv Sci Tec. 2018;45:213–219.
   Web of Science ®Google Scholar
• Kalhori V, Tornquist K. MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells. Mol Cell Endocrinol. 2015;404:113–122.
   PubMed Web of Science ®Google Scholar
• Kong L, Yuan Q, Zhu H, et al. The suppression of prostate LNCaP cancer cells growth by selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis. Biomaterials. 2011;32:6515–6522.
   PubMed Web of Science ®Google Scholar
• Laha D, Pramanik A, Maity J, et al. Interplay between autophagy and apoptosis mediated by copper oxide nanoparticles in human breast cancer cells MCF7. Biochim Biophys Acta. 2014;1840:1–9.
   PubMed Web of Science ®Google Scholar